A phase I study of the mammalian target of rapamycin inhibitor sirolimus and MEC chemotherapy in relapsed and refractory acute myelogenous leukemia.
scientific article published on 20 October 2009
Author/s
author: Dan T Vogl, David L. Porter, Edward A. Stadtmauer, Noelle V. Frey, Elizabeth O. Hexner, Alison Wakoff Loren, Selina Luger, Sunita D Nasta, Donald E Tsai, Alexander E Perl, Margaret T Kasner, Stephen J Schuster, Adam Bagg
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.